Guardant Health, Inc.
Clinical trials sponsored by Guardant Health, Inc., explained in plain language.
-
Blood test aims to catch lung cancer before it spreads
Diagnosis OngoingThis study is testing a new blood test (GuardantLUNAR-2) to see how well it can detect lung cancer in people at high risk. About 12,000 smokers aged 50-80 will give a blood sample before their regular low-dose CT scan. The goal is to find out if the blood test is accurate enough …
Sponsor: Guardant Health, Inc. • Aim: Diagnosis
Last updated Jul 08, 2026 00:00 UTC
-
Blood test could revolutionize colon cancer screening
Diagnosis OngoingThis study is testing a new blood test called LUNAR-2 that looks for DNA from colorectal cancer in the bloodstream. It involves over 44,000 average-risk adults aged 45-84 who are already scheduled for a screening colonoscopy. The goal is to see how well this blood test can detect…
Sponsor: Guardant Health, Inc. • Aim: Diagnosis
Last updated Jun 27, 2026 12:33 UTC